Taylor, P.C.; Laedermann, C.; Alten, R.; Feist, E.; Choy, E.; Haladyj, E.; De La Torre, I.; Richette, P.; Finckh, A.; Tanaka, Y.
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience. J. Clin. Med. 2023, 12, 4527.
https://doi.org/10.3390/jcm12134527
AMA Style
Taylor PC, Laedermann C, Alten R, Feist E, Choy E, Haladyj E, De La Torre I, Richette P, Finckh A, Tanaka Y.
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience. Journal of Clinical Medicine. 2023; 12(13):4527.
https://doi.org/10.3390/jcm12134527
Chicago/Turabian Style
Taylor, Peter C., Cedric Laedermann, Rieke Alten, Eugen Feist, Ernest Choy, Ewa Haladyj, Inmaculada De La Torre, Pascal Richette, Axel Finckh, and Yoshiya Tanaka.
2023. "A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience" Journal of Clinical Medicine 12, no. 13: 4527.
https://doi.org/10.3390/jcm12134527
APA Style
Taylor, P. C., Laedermann, C., Alten, R., Feist, E., Choy, E., Haladyj, E., De La Torre, I., Richette, P., Finckh, A., & Tanaka, Y.
(2023). A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience. Journal of Clinical Medicine, 12(13), 4527.
https://doi.org/10.3390/jcm12134527